Bee Vectoring Technologies Signs First Commercial Industry Partnership
Product In-Licensing Partnership with CBC BIOGARD Accelerates BVT's EU Market Entry
- Mississauga, Ontario and Sacramento, California--(Newsfile Corp. - October 14, 2021) - Bee Vectoring Technologies International Inc. (CSE: BEE) (OTCQB: BEVVF) (CVE: BEE) (the "Company" or "BVT") today announced its first commercial agreement with BIOGARD, a division of CBC (Europe) S.r.l., one of the leading bioprotectant companies in Europe.
- Through the agreement, BVT will have exclusive access to BIOGARD's biological insecticide Beauveria bassiana ATCC 74040 for bee vectoring uses throughout the European Union and Switzerland.
- It is also a clear indication that the industry has begun to recognize the value of our bee vectoring system as an effective way to deliver crop protection."
- Through the agreement, BVT will develop a biological insecticide solution for delivery to crops through BVT's proprietary bee vectoring platform using BIOGARD's active substance registration.